Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134,733 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging.
Park JH, von Maltzahn G, Zhang L, Schwartz MP, Ruoslahti E, Bhatia SN, Sailor MJ. Park JH, et al. Among authors: zhang l. Adv Mater. 2008 May 5;20(9):1630-1635. doi: 10.1002/adma.200800004. Adv Mater. 2008. PMID: 21687830 Free PMC article. No abstract available.
Molecular profiling of heart endothelial cells.
Zhang L, Hoffman JA, Ruoslahti E. Zhang L, et al. Circulation. 2005 Sep 13;112(11):1601-11. doi: 10.1161/CIRCULATIONAHA.104.529537. Epub 2005 Sep 6. Circulation. 2005. PMID: 16144998
Biomimetic amplification of nanoparticle homing to tumors.
Simberg D, Duza T, Park JH, Essler M, Pilch J, Zhang L, Derfus AM, Yang M, Hoffman RM, Bhatia S, Sailor MJ, Ruoslahti E. Simberg D, et al. Among authors: zhang l. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):932-6. doi: 10.1073/pnas.0610298104. Epub 2007 Jan 10. Proc Natl Acad Sci U S A. 2007. PMID: 17215365 Free PMC article.
Peptide targeting of tumor lymph vessels.
Laakkonen P, Zhang L, Ruoslahti E. Laakkonen P, et al. Among authors: zhang l. Ann N Y Acad Sci. 2008;1131:37-43. doi: 10.1196/annals.1413.003. Ann N Y Acad Sci. 2008. PMID: 18519957 Review.
Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies.
Hu-Lowe DD, Chen E, Zhang L, Watson KD, Mancuso P, Lappin P, Wickman G, Chen JH, Wang J, Jiang X, Amundson K, Simon R, Erbersdobler A, Bergqvist S, Feng Z, Swanson TA, Simmons BH, Lippincott J, Casperson GF, Levin WJ, Stampino CG, Shalinsky DR, Ferrara KW, Fiedler W, Bertolini F. Hu-Lowe DD, et al. Among authors: zhang l. Cancer Res. 2011 Feb 15;71(4):1362-73. doi: 10.1158/0008-5472.CAN-10-1451. Epub 2011 Jan 6. Cancer Res. 2011. PMID: 21212415 Free PMC article.
134,733 results
You have reached the last available page of results. Please see the User Guide for more information.